C57BL/6JCya-Fgf9em1flox/Cya
Common Name:
Fgf9-flox
Product ID:
S-CKO-02412
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fgf9-flox
Strain ID
CKOCMP-14180-Fgf9-B6J-VA
Gene Name
Product ID
S-CKO-02412
Gene Alias
Eks; FGF-9; Fgf4b; GAF; HBGF-9
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
14
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Fgf9em1flox/Cya mice (Catalog S-CKO-02412) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000022545
NCBI RefSeq
NM_013518
Target Region
Exon 2
Size of Effective Region
~1.7 kb
Detailed Document
Overview of Gene Research
Fgf9, or Fibroblast growth factor 9, is a cytokine involved in multiple biological processes. It modulates cell proliferation, differentiation, and motility, and is associated with pathways like ERK1/2-GSK-3β, PI3K/AKT/Hippo, MAPK/ERK, and Wnt/β-catenin. It is crucial for maintaining normal physiological functions and its dysregulation is linked to various diseases [1,2,3,5]. Genetic models, especially KO/CKO mouse models, have been instrumental in understanding its functions.
In NASH-driven HCC, AAV-mediated knockdown of FGF9 reduced the hepatic tumor burden in mouse models, indicating its role in promoting tumor formation via the ECM pathway [1]. In osteoporosis, Fgf9 loss-of-function mutation (S99N) in mice inhibited bone marrow adipose tissue formation and alleviated ovariectomy-induced bone loss, revealing its role in regulating bone-fat balance [2]. Fgf9-/-mice exhibited 100% penetrance of cleft palate, highlighting its importance in palatogenesis through regulating HAS2 expression via the Wnt/β-catenin/TCF7L2 pathway [3]. The Fgf9S99N mutation in mice led to reduced ameloblasts, impaired enamel formation, and increased apoptosis in the cervical loop, showing its essentiality for dental epithelial stem cell survival and enamel formation [4]. In TM3 mouse Leydig progenitor cells, FGF9 promoted cell proliferation and tumorigenesis, and in allograft mouse models, it enhanced the tumorigenesis of TM3 cells [5]. Hepatic FGF9 knockdown in DIO mice aggravated the fatty liver phenotype, while its overexpression alleviated hepatic steatosis, suggesting its role in regulating hepatic lipid metabolism [6]. Deletion of Fgf9 in GABAergic neurons in mice caused epilepsy, indicating its role in GABAergic neuron survival and epilepsy pathology [7].
In conclusion, Fgf9 plays essential roles in various biological processes such as tissue development, metabolism, and maintaining cellular homeostasis. Studies using KO/CKO mouse models have significantly contributed to understanding its role in diseases like NASH-driven HCC, osteoporosis, cleft palate, dental development, fatty liver, and epilepsy, providing potential therapeutic targets for these conditions.
References:
1. Zhang, Lei, Zhang, Qing, Teng, Da, Chang, Yongsheng, Zhang, Huabing. 2023. FGF9 Recruits β-Catenin to Increase Hepatic ECM Synthesis and Promote NASH-Driven HCC. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2301166. doi:10.1002/advs.202301166. https://pubmed.ncbi.nlm.nih.gov/37566761/
2. Chen, Mingmei, Liang, Hui, Wu, Min, Wang, Zhugang, Tang, Lingyun. 2024. Fgf9 regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis by PI3K/AKT/Hippo and MEK/ERK signaling. In International journal of biological sciences, 20, 3461-3479. doi:10.7150/ijbs.94863. https://pubmed.ncbi.nlm.nih.gov/38993574/
3. Sun, Yidan, Ying, Xiyu, Li, Ruomei, Shi, Jiajun, Chen, Zhenqi. 2022. FGF9 Promotes Expression of HAS2 in Palatal Elevation via the Wnt/β-Catenin/TCF7L2 Pathway. In Biomolecules, 12, . doi:10.3390/biom12111639. https://pubmed.ncbi.nlm.nih.gov/36358989/
4. Tang, Lingyun, Chen, Mingmei, Wu, Min, Zhang, Chenping, Wang, Zhugang. 2024. Fgf9 promotes incisor dental epithelial stem cell survival and enamel formation. In Stem cell research & therapy, 15, 293. doi:10.1186/s13287-024-03894-y. https://pubmed.ncbi.nlm.nih.gov/39256850/
5. Chang, Ming-Min, Weng, Han-Yu, Lai, Meng-Shao, Wang, Chia-Yih, Huang, Bu-Miin. 2022. FGF9 promotes cell proliferation and tumorigenesis in TM3 mouse Leydig progenitor cells. In American journal of cancer research, 12, 5613-5630. doi:. https://pubmed.ncbi.nlm.nih.gov/36628285/
6. Zhao, Fanrong, Zhang, Lei, Zhang, Menglin, Zhang, Jun, Chang, Yongsheng. 2022. FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism. In Frontiers in pharmacology, 13, 850128. doi:10.3389/fphar.2022.850128. https://pubmed.ncbi.nlm.nih.gov/35517790/
7. Guo, Moran, Cui, Can, Song, Xueqin, Duan, Weisong, Li, Chunyan. 2021. Deletion of FGF9 in GABAergic neurons causes epilepsy. In Cell death & disease, 12, 196. doi:10.1038/s41419-021-03478-1. https://pubmed.ncbi.nlm.nih.gov/33608505/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen